Start at the end of the page to follow the storyline.
22 Feb 2021 – he just has to keep pushing the vax – one would think his life depended on it – or some part of it!
20 Nov 2020 – Boris Johnson ‘acted illegally’ over jobs for top anti-Covid staff – Legal action targets appointments of Dido Harding, Kate Bingham and Mike Coupe
Apart from his “research” work, Luke O’Neill is the “go to” expert for RTE where he is a regular guest who pushes the gvt and NPHET narrative. But in Nov 2020 he took it on himself to start indoctrinating Irish school children. He also decided to add to their anxiety by talking about an asteroid hitting the earth! Quite apart from that – he gives false info because the covid vaccines are not vaccines in the traditional sense of the word so they are not actually “Vaccines” at all. They are a new RNA which is DNA altering coctail.
Prof-iteer Luke O’Neill indoctrinating Irish School Children in Wexford – 21 Nov 2020
Listen carefully – The Irish Inquirer caught up with Prof. Luke O’Neill in the street and asked him about concerns over vaccines – listen to the part about the first hundreds of thousands of people first getting the vaccines will be the test subjects because they have not time to trial it. – 27 Nov 2020
UK Coronavirus Vaccine Taskforce Chief Kate Bingham manages investments for drug firms and of course Kate is an investor in Luke O’Neill’s Pharma company, Sitryx – Luke being one of the regular pushers of the covid story on RTE Ireland.
The vaccine being developed by Luke O’Neill’s company is not a preventative vaccine in the old sense of the word as we knew “vaccine”. No, it is a therapeutic vaccine (not sure why it is called vaccine then) and may require more than one dose.
Now, the question is – if a person tests positive using the controversial PCR tests after 30 – 60 cycles, does that then mean that the person diagnosed as a “positive case” while perfectly healthy should be given a few doses of Luke/Kate’s vaccine? Phew! some cash haul there! Unfortunately they say we will still have to wear masks and social distance even AFTER the vax despite a low death rate.
Kate Bingham: well-connected but under-fire UK vaccines chief – sharing secrets with private firms – 10 Nov 2020
Professor Luke O’Neill, who is a professor of biochemistry at Trinity, has been awarded €985,950 for his continued research following his discovery of an off-switch for inflammation in the body called itaconate. This project will look at itaconate to develop potential new treatments for inflammatory diseases such as Alzheimer’s disease. – 2 Nov 2020
Is Luke O’Neill a Trojan Horse for Mandatory Vaccines? – 11 Oct 2020
Irish biotech, Inflazome, co-founded by Professor O’Neill and Australian researcher Professor Matt Cooper has been acquired by Swiss healthcare giant Roche in a landmark deal worth €380 million. – 21 Sept 2020
Professor Luke O’Neill wants to stop both the virus and the massive immune response, and he is exploring how a naturally-occurring substance in the body could do that. The substance is called itaconate, and it is a byproduct of a well-known biochemical pathway in cells called the Krebs cycle. – May 2020
Sitryx signs major deal with Eli Lily – If the partnership achieves all its targets, Sitryx could receive up to $820m in addition to royalty payments on sales. In return, Sitryx said it will give Eli Lily the exclusive rights to globally develop and commercialize the four compounds. – 3 April 2020
Understanding immune system switches will spark new drugs – Luke O’Neill- 9 Jan 2019
Opsona Therapeutics, one of the most heavily backed Irish biotech start-ups, is to be wound up after 14 years in which it raised more than €76,500,000 in funding. A decision was taken to put the company into a creditors’ voluntary liquidation after the search for a development partner or buyer for its main drug therapy was fruitless. – 13 Jan 2019
Sitryx, a new biopharma start-up co-founded by a professor of biochemistry at Trinity College Dublin, has raised $30 million in a funding round to help it develop disease-modifying therapeutics. – 10 – Oct 2018
Emerging Drug Developer: Opsona Therapeutics – The runway at Ireland’s Opsona Therapeutics just got three years longer. That’s how much time investors bought when they chipped in on a $23 million Series B last week – 23 Feb 2009
Opsona is a new biotechnology enterprise based at St James’ Hospital, and is associated with Trinity College Dublin (TCD). The start-up company hopes to lead a new wave of Irish companies developing biotechnology-based drugs.
Wyeth signs deal with Ireland’s Opsona – 14 Feb 2006
TCD start-up Opsona secures ?6.25m – 25 Feb 2005
Wellcome and GSK both fund Luke O’Neil. Wellcome is the company who tried out ANIMAL vaccines on children in orphanages. Detailed in the Mother & Baby investigation
Over 2,700 children living in Mother and Baby Homes and Orphanages in Ireland in the 1960s and 70s were used as Human Guinea Pigs in illegal Medical Trials.